Browsing Category
Healthcare
Johnson and Johnson Acquires Neuroscience Biotech Firm Intra Cellular in $146 Billion Dollar Deal
In a significant move that marks the largest biotech acquisition since 2023, Johnson & Johnson has announced its agreement to purchase neuroscience drugmaker Intra-Cellular Therapies for £14.6 billion. The New Jersey-based…
Moderna Share Price Plummets as Revenue Forecast Takes Sharp Downturn
In a devastating blow to investor confidence, Moderna's shares experienced a dramatic decline of up to 22 per cent on Monday following disappointing sales forecasts from the US biotech giant.
The Boston-headquartered company revised its…
Alliance Pharma Set For £350 Million Pound Takeover as Board Backs Dbay Bid
The struggling consumer healthcare company Alliance Pharma appears poised to exit London's junior stock exchange following a £350 million takeover bid from activist investor Dbay Advisors. The Isle of Man-based investment firm, which holds…
London Based Obesity Drug Innovator Secures Record Breaking $411 Million Dollar Investment Round
A groundbreaking series A funding round has positioned London-based Verdiva Bio at the forefront of the obesity treatment sector, securing an impressive $411 million investment. This remarkable achievement stands as Europe's largest…
Groundbreaking UK Blood Protein Study Set to Revolutionise Healthcare Investment Landscape
A landmark research initiative analysing blood proteins could catalyse significant advancements in disease treatment and prevention, presenting substantial opportunities for healthcare sector investors. The extensive UK-based study, backed…
GSK Set to Acquire US Biotechnology Company IDRx in $1 Billion Dollar Deal
British pharmaceutical giant GSK is in advanced negotiations to acquire IDRx, a Massachusetts-based biotechnology company, in a deal valued at approximately $1 billion. The announcement is expected to coincide with the upcoming JP Morgan…
NHS Winter Crisis Leads to Critical Two Day Accident and Emergency Waits at Nine Major Hospitals
The National Health Service faces unprecedented pressure as nine hospitals across England declare critical incidents, with patients experiencing wait times of up to two days in Accident and Emergency departments. The crisis, exacerbated by…
Danish Pharmaceutical Giant Novo Nordisk Sponsored UK Pharmacies to Boost Weight Loss Drug Sales
Novo Nordisk, the Danish pharmaceutical powerhouse, has invested hundreds of thousands of pounds in sponsorship deals with major UK pharmacy chains, including Boots and Lloyds, to enhance sales of its weight-loss medications. The…
Pharmacy Sector Sees Major Consolidation as One in Ten Shops Change Hands
The UK pharmacy sector witnessed a significant wave of consolidation as nearly one in ten pharmacies were acquired through mergers and acquisitions in the 12 months to June 2024, amid mounting profit pressures and rising operational costs.…
The Growing Crisis of Child Nutrition in British Schools and its Economic Impact
Britain's children are facing an unprecedented health crisis as poor nutrition and rising obesity rates continue to plague the nation's youth. Recent NHS data reveals a stark reality: one in five Year 6 pupils are now classified as obese,…
AstraZeneca Pays £45 Million Pounds to Russian Doctors Amid Growing UK Support for Ukraine
British pharmaceutical giant AstraZeneca has distributed approximately £45 million to Russian healthcare professionals and organisations since the outbreak of the Ukraine war, despite mounting UK military support for Kyiv.
The…
Weight Loss Drug Marketing Creates Wild West Environment in British Healthcare Market
The aggressive marketing of weight-loss injections to British consumers has sparked significant concern amongst healthcare experts, who are witnessing what they describe as a "wild west" approach to pharmaceutical promotion. Online…
NHS Reform Paralysis Threatens Financial Efficiency and Service Delivery
Critical concerns are emerging regarding the National Health Service's operational effectiveness as it awaits Wes Streeting's comprehensive 10-year reform plan. The Institute for Public Policy Research (IPPR) has raised significant alarms…
UK Biotech Pioneer Aucatzyl Takes Bold Step in Cancer Treatment Revolution
A groundbreaking personalised cancer treatment is emerging from an unexpected location: Stevenage High Street. UK biotech firm Autolus has received FDA approval to manufacture and distribute its innovative Car-T cell therapy, Aucatzyl,…
Novo Nordisk Market Value Plummets $100 Billion After Weight Loss Drug Trial Falls Short
Danish pharmaceutical giant Novo Nordisk witnessed a staggering $100 billion erosion in market value following disappointing results from its latest obesity drug trial. The company's shares experienced their most significant single-day…
UK Weight Loss Drug Market Soars Past 500,000 Users as Private Sales Outpace NHS Access
The United Kingdom's weight-loss medication market has witnessed an unprecedented surge, with more than 500,000 individuals now utilising revolutionary anti-obesity drugs Mounjaro and Wegovy. This dramatic increase has occurred within just…
New NHS Breast Cancer Drug Brings Hope to UK Healthcare Market
In a significant development for the UK healthcare sector, the NHS has announced the introduction of a groundbreaking once-daily tablet for advanced breast cancer treatment. This strategic move is projected to benefit over 1,000 women and…
AstraZeneca Board Welcomes Arm Holdings CEO in Strategic Technology Push
In a significant move strengthening its technological capabilities, AstraZeneca has appointed Arm Holdings Chief Executive Rene Haas to its board as a non-executive director, effective from next month. The appointment comes as Britain's…